UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

MIND MEDICINE (MINDMED) INC.

(Exact name of registrant as specified in its charter)

 

 

British Columbia   98-1582438
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

One World Trade Center
Suite 8500
New York, New York
  10007
(Address of principal executive offices)   (Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class to be so registered   Name of each exchange on which each class is to be registered
Subordinate Voting Shares   The Nasdaq Stock Market LLC

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), please check the following box.  x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), please check the following box.  ¨

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ¨

 

Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-254859

 

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 

 

 

INFORMATION REQUIRED IN REGISTRATION STATEMENT

 

Item 1. Description of Registrant’s Securities to be Registered.

 

The securities to be registered consist of subordinate voting shares (“Subordinate Voting Shares”) of Mind Medicine (MindMed) Inc. (the “Registrant”). The description of the Registrant’s Subordinate Voting Shares under the sections captioned “Description of Share Capital,” “Certain Canadian Federal Income Tax Considerations,” and “Certain U.S. Federal Income Tax Considerations” in the short form base shelf prospectus, which is included in the Registrant’s registration statement on Form F-10 (File No. 333-254859) (the “Registration Statement”) initially filed with the Securities and Exchange Commission on March 30, 2021, as subsequently amended by any amendments to such Registration Statement, is incorporated herein by reference.

 

Item 2. Exhibits.

 

Under the “Instructions as to Exhibits” section of Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are to be registered on The Nasdaq Stock Market LLC and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

  MIND MEDICINE (MINDMED) INC.
  (Registrant)
   
  Date: April 22, 2021
   
  By: /s/ Jamon Alexander (“JR”) Rahn
  Name: Jamon Alexander (“JR”) Rahn
  Title: Chief Executive Officer